Diagnosis of Cold Agglutinin Disease • The Blood Project

Learning objectives

After completing this quiz, the learner should be able to:

recognize CAD as a diagnostic pattern rather than a single test
interpret DAT results in the context of complement-mediated hemolysis
distinguish pathogenic cold agglutinins from incidental antibodies
understand the clinical importance of thermal amplitude
differentiate primary CAD from secondary cold agglutinin syndromes
identify common laboratory and conceptual diagnostic pitfalls

Which statement best reflects how CAD is diagnosed?

a

CAD is diagnosed by a high cold agglutinin titer

Titers alone correlate poorly with clinical relevance

b

CAD is diagnosed by a positive DAT

DAT positivity is supportive but not sufficient

c

CAD is diagnosed by integrating hemolysis, complement, temperature dependence, and clonality

CAD is a clinicopathologic pattern that emerges from convergence

d

CAD is diagnosed once anemia and acrocyanosis are present

Symptoms raise suspicion but do not define mechanism

Which statement about hemolysis in CAD is most accurate?

a

Hemolysis is usually severe and biochemically dramatic

Many patients have modest laboratory abnormalities

b

Hemolysis is often chronic, compensated, and laboratory-subtle

This contributes to diagnostic delay

c

Hemolysis severity closely tracks hemoglobin level

Compensated hemolysis may preserve hemoglobin

d

Hemolysis is absent unless anemia is profound

Ongoing red cell destruction may be present with mild anemia

Which DAT pattern most strongly supports CAD?

a

IgG negative, C3 positive

This pattern defines complement-mediated hemolysis

b

IgG positive, C3 negative

Typical of warm AIHA

c

IgG negative, C3 positive

This pattern defines complement-mediated hemolysis

d

DAT negative

Does not support immune-mediated hemolysis

A patient with cold-induced symptoms, chronic anemia, and elevated LDH has a DAT positive for C3 and weakly positive for IgG. What is the most appropriate interpretation?

a

CAD is excluded

CAD is not excluded by weak IgG positivity

b

This confirms mixed autoimmune hemolytic anemia

Mixed AIHA requires stronger, consistent IgG findings

c

Steroids should be started immediately

Steroids target the wrong mechanism in CAD

d

The IgG result should be interpreted cautiously within the broader pattern

Pattern recognition supersedes isolated findings

Why is thermal amplitude more clinically informative than cold agglutinin titer?

a

It predicts bone marrow clone size

Clone size correlates poorly with severity

b

It determines whether antibodies bind at physiologic temperatures

Binding closer to core temperature drives disease

c

It correlates directly with hemoglobin level

Symptoms and hemoglobin often diverge

d

It distinguishes IgM from IgG antibodies

Immunoglobulin class is determined separately

Which feature most strongly supports primary CAD rather than secondary cold agglutinin syndrome?

a

Recent Mycoplasma pneumoniae infection

Typical of secondary disease

b

Polyclonal cold agglutinins

Suggest reactive antibodies

c

Resolution of hemolysis with antibiotics

Supports a secondary process

d

Persistent hemolysis with monoclonal IgM

This defines primary CAD

Which CBC abnormality should raise suspicion for cold agglutinin interference?

a

Low MCV with normal MCHC

Not characteristic

b

Elevated MCHC with implausible indices

RBC clumping distorts automated analysis

c

Normal RBC count with anemia

Nonspecific

d

Isolated thrombocytopenia

Unrelated to cold agglutinins

Which presentation should most strongly raise suspicion for CAD?

a

Acute anemia immediately after transfusion

Suggests transfusion reaction

b

Severe anemia with splenomegaly

More typical of warm AIHA

c

Anemia with positive ANA

Nonspecific

d

Chronic anemia with cold-induced acrocyanosis and DAT positivity

Classic clinical pattern

A patient presents with anemia and cold-triggered symptoms. What is the most appropriate initial diagnostic evaluation?

a

Bone marrow biopsy

Not first-line

b

DAT, hemolysis markers, reticulocyte count, cold agglutinin testing

Establishes relevance and mechanism

c

Thermal amplitude testing alone

Helpful but not sufficient

d

CT scan for lymphoma staging

Premature without diagnostic confirmation

Which step is most important before labeling disease as primary CAD?

a

Assessment for infection, autoimmune disease, or overt lymphoma

Secondary causes must be excluded

b

Repeat cold agglutinin titer in 6 months

Titers alone are insufficient

c

Immediate bone marrow biopsy in all cases

Context-dependent

d

Empiric antibiotics

Not diagnostic

What best predicts pathogenicity?

Click for Answer

Thermal amplitude, not titer

What defines the mechanism in CAD?

Click for Answer

C3 deposition on DAT

Sort each feature into the correct category

Chronic or relapsing hemolysis

Isolated C3-positive DAT

Weak IgG DAT positivity

Mild anemia

Monoclonal IgM

Symptoms triggered by mild cold exposure

Low-titer cold agglutinin

Absence of overt lymphoma

Supports CAD diagnosis (in context)

Does not establish CAD alone

Match each finding to its diagnostic implication:

Winter symptoms + air-conditioning sensitivity

C3-positive DAT

Low titer, high thermal amplitude

Clinically relevant temperature dependence

Complement-mediated hemolysis

Potentially severe disease

Correct! Sorry, Incorrect.

Closing Note

Diagnosis in cold agglutinin disease is not established by a single test or threshold. It emerges from pattern recognition over time, integrating serology, hemolysis, complement involvement, temperature dependence, and clinical behavior.

The greatest diagnostic errors in CAD arise not from missing data, but from over-weighting individual findings: titers without context, DAT patterns without phenotype, laboratory stability without attention to symptoms, or cold antibodies without evidence of disease.

Expert diagnosis requires resisting binary thinking. Cold agglutinin disease declares itself through consistency, persistence, and consequence, not through any single result. The task is not to label prematurely, but to locate the patient accurately along a biologic and clinical spectrum—and to remain willing to revise that judgment as new information emerges.

In CAD, diagnosis is not a moment.
It is a process of alignment between biology, behavior, and time.